Physician profile
Jose E Lozada
NPI 1720063050
$1,444.40
in general payments reported to CMS, 2019-2025
8 companies · $19.95 in 2025
The $19.95 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $13.00 · 2021: $54.26 · 2022: $58.77 · 2024: $1,145 · 2025: $19.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125 · Food and Beverage: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
| Food and Beverage | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,125.00 | 2024 | Keytruda |
| Abbvie INC. | $125.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $58.85 | 2022-2025 | Rybrevant |
| Ipsen Biopharmaceuticals, INC | $47.68 | 2019-2021 | |
| Pbg Puerto Rico LLC | $35.00 | 2021 | |
| Exact Sciences Corporation | $20.00 | 2024 | Cologuard Collection Kit |
| Adc Therapeutics America, INC. | $19.87 | 2022 | |
| Verastem, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Lozada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.